Literature DB >> 29101086

Beyond Idiopathic Pulmonary Fibrosis Diagnosis: Multidisciplinary Care With an Early Integrated Palliative Approach Is Associated With a Decrease in Acute Care Utilization and Hospital Deaths.

Meena Kalluri1, Francisca Claveria2, Emily Ainsley2, Maged Haggag3, Susan Armijo-Olivo4, Janice Richman-Eisenstat3.   

Abstract

CONTEXT: Idiopathic pulmonary fibrosis (IPF) is a progressive, incurable interstitial lung disease with heavy symptom burden and poor quality of life. The last year of life is characterized by increased acute care utilization and hospital deaths. Clinical guidelines recommend early integration of palliative care but are rarely implemented. In 2012, we reorganized our clinic into a multidisciplinary team comprising two pulmonologists (expertise in interstitial lung disease and palliative respiratory care, respectively), nurse, respiratory therapist, physiotherapist, and a dietitian. We adopted an early integrated palliative approach with a focus on early symptom management and advance care planning starting at the first clinic visit. We designed a Multidisciplinary collaborative (MDC) care model with emphasis on community-based care to manage patients in their homes and support caregivers.
OBJECTIVES: Exploratory analysis of this model's association with acute care utilization in the last year of life and location of death was undertaken.
METHODS: Data from deceased IPF patients before and after 2012 (non-MDC and MDC care model, respectively) were collected, and statistical analysis was performed.
RESULTS: Patients in MDC care were 24.2 times less likely to have respiratory-related emergency room visits (95% CI: 3.12-187.44, P = 0.002), 2.32 times less likely to have respiratory-related hospitalizations (95% CI: 0.95-5.6, P = 0.064). The odds of achieving a home or hospice death in MDC care were 9.2 times compared to non-MDC care, who die mostly in the hospital (95% CI: 1.14-75, P = 0.037).
CONCLUSIONS: MDC care model for IPF was associated with reduced health care use in the last year of life and more home deaths.
Copyright © 2017 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Idiopathic pulmonary fibrosis; early integrated palliative approach; home deaths; interstitial lung disease; multidisciplinary collaborative care; palliative care

Mesh:

Year:  2017        PMID: 29101086     DOI: 10.1016/j.jpainsymman.2017.10.016

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  14 in total

1.  Early referral to palliative care in IPF - pitfalls and opportunities in clinical trials.

Authors:  Meena Kalluri; Elisabeth Bendstrup; Kathleen O Lindell; Giovanni Ferrara
Journal:  Respir Res       Date:  2020-07-08

2.  Unmet Needs for Palliation in Fibrotic Interstitial Lung Disease.

Authors:  Sumeet Vimal Kishore Singhania; Shriram Sudhakar Shenoy
Journal:  Indian J Palliat Care       Date:  2018 Jul-Sep

3.  The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the Current Evidence and Future Perspectives.

Authors:  Federica Furini; Aldo Carnevale; Gian Luca Casoni; Giulio Guerrini; Lorenzo Cavagna; Marcello Govoni; Carlo Alberto Sciré
Journal:  Front Med (Lausanne)       Date:  2019-10-31

4.  Care programs and their components for patients with idiopathic pulmonary fibrosis: a systematic review.

Authors:  Anouk Delameillieure; Sarah Vandekerkhof; Bastiaan Van Grootven; Wim A Wuyts; Fabienne Dobbels
Journal:  Respir Res       Date:  2021-08-16

5.  Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.

Authors:  Joao A de Andrade; Tejaswini Kulkarni; Megan L Neely; Anne S Hellkamp; Amy Hajari Case; Daniel A Culver; Kalpalatha Guntupalli; Shaun Bender; Craig S Conoscenti; Laurie D Snyder
Journal:  Respir Res       Date:  2022-01-07

6.  The Value of the Surprise Question to Predict One-Year Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Cohort Study.

Authors:  Catharina C Moor; Nelleke C Tak van Jaarsveld; Catherine Owusuaa; Jelle R Miedema; Sara Baart; Carin C D van der Rijt; Marlies S Wijsenbeek
Journal:  Respiration       Date:  2021-05-27       Impact factor: 3.580

7.  A narrative literature review of palliative care regarding patients with idiopathic pulmonary fibrosis.

Authors:  Yasuko Igai
Journal:  Nurs Open       Date:  2018-06-03

8.  Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life.

Authors:  K Rajala; J T Lehto; E Sutinen; H Kautiainen; M Myllärniemi; T Saarto
Journal:  BMC Pulm Med       Date:  2018-11-20       Impact factor: 3.317

Review 9.  Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis.

Authors:  Paloma Millan-Billi; Candela Serra; Ana Alonso Leon; Diego Castillo
Journal:  Med Sci (Basel)       Date:  2018-07-24

10.  The impact of palliative care on quality of life, anxiety, and depression in idiopathic pulmonary fibrosis: a randomized controlled pilot study.

Authors:  Katherine Janssen; Drew Rosielle; Qi Wang; Hyun Joo Kim
Journal:  Respir Res       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.